JANE STREET GROUP, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,685,883
-40.5%
146,982
+31.2%
0.00%0.0%
Q2 2023$2,834,391
-68.0%
111,987
-59.2%
0.00%
-75.0%
Q1 2023$8,851,276
+1777.1%
274,799
+975.8%
0.00%
Q4 2022$471,542
-92.9%
25,544
-89.7%
0.00%
-100.0%
Q3 2022$6,671,000
+1095.5%
247,065
+512.1%
0.00%
Q2 2022$558,000
-91.0%
40,363
-87.2%
0.00%
-100.0%
Q1 2022$6,168,000
+152.1%
316,336
+111.0%
0.00%
Q4 2021$2,447,000
+59.8%
149,900
+172.7%
0.00%
Q3 2021$1,531,000
-35.3%
54,961
-31.1%
0.00%
-100.0%
Q2 2021$2,366,000
-15.0%
79,800
-19.9%
0.00%0.0%
Q1 2021$2,784,000
+7.7%
99,600
+9.1%
0.00%0.0%
Q4 2020$2,586,000
+153.0%
91,255
+124.6%
0.00%
Q3 2020$1,022,000
+223.4%
40,632
+102.9%
0.00%
-100.0%
Q1 2019$316,000
+15.3%
20,029
+47.4%
0.00%0.0%
Q4 2018$274,000
-60.0%
13,588
-29.1%
0.00%
-50.0%
Q4 2017$685,000
+190.3%
19,172
+177.9%
0.00%
+100.0%
Q4 2015$236,0006,9000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders